Trial Profile
Efficacy of Angiotensin II Receptor Blocker for Patients with Obstructive Sleep Apnea Syndrome
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 19 Jun 2013 New trial record